Stockreport

Alimera Sciences: Deal Closing After All, CVR Still Attractive [Seeking Alpha]

Alimera Sciences, Inc.  (ALIM) 
Last alimera sciences, inc. earnings: 4/29 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alimerasciences.com/investor-relations
PDF Follow Summary Alimera Sciences, Inc. is being acquired by ANI Pharmaceuticals for $5.50 per share, with a contingent value right, or CVR, potentially adding up to [Read more]